Detalhe da pesquisa
1.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611518
2.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420616
3.
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial.
JAMA Surg
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38865139
4.
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study.
J Clin Oncol
; 41(21): 3663-3669, 2023 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459755
5.
Current status of cediranib: the rapid development of a novel anti-angiogenic therapy.
Future Oncol
; 5(4): 421-32, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19450171
6.
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technol Assess
; 23(64): 1-88, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852579
7.
Capecitabine as adjuvant treatment for stage III colon cancer.
N Engl J Med
; 352(26): 2696-704, 2005 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15987918
8.
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors.
Clin Cancer Res
; 13(2 Pt 1): 523-31, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255274
9.
Corporate crisis management managing a major crisis in a chemical facility.
J Hazard Mater
; 159(1): 92-104, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18054433
10.
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies.
Eur J Cancer
; 103: 259-266, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30292142
11.
Chemotherapy in metastatic colorectal cancer.
Surg Oncol
; 16(1): 65-70, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17521906
12.
Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
J Clin Oncol
; 23(21): 4719-25, 2005 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16034047
13.
Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
Oncotarget
; 7(16): 22650-64, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26967059
14.
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
J Clin Oncol
; 22(11): 2084-91, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15169795
15.
Liver metastases from breast cancer: management of patients with significant liver dysfunction.
Cancer Treat Rev
; 31(1): 35-48, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15707703
16.
Adjuvant treatment strategies for early colon cancer.
Drugs
; 65(14): 1935-47, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16162019
17.
Benefits and drawbacks of the use of oral fluoropyrimidines as single-agent therapy in advanced colorectal cancer.
Clin Colorectal Cancer
; 5 Suppl 1: S47-50, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15871766
18.
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study.
Clin Colorectal Cancer
; 5(2): 101-7, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16098250
19.
A phase I clinical and pharmacokinetic study of Ro 31-7453 given as a 7- or 14-day oral twice daily schedule every 4 weeks in patients with solid tumors.
Clin Cancer Res
; 10(13): 4374-82, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15240525
20.
Tumour-targeted drug and gene delivery: principles and concepts.
Expert Rev Mol Med
; 6(19): 1-17, 2004 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-15387893